Ceftriaxone & Tazobactam Injection 562.5 mg Supplier for Cape Town, South Africa
Reliable Antibiotic Injection Manufactured in India
Ernest Oncology brings Ceftriaxone & Tazobactam Injection 562.5 mg, a sterile injectable antibiotic formulation containing Ceftriaxone 500 mg and Tazobactam 62.5 mg. Produced in India using advanced pharmaceutical technology, this medicine is manufactured in WHO-GMP certified facilities with strict quality controls to ensure consistent purity, safety, and pharmaceutical excellence.
The injection is intended for intravenous (IV) and intramuscular (IM) administration under the supervision of qualified healthcare professionals.
Cape Town Pharmaceutical Market Information
Cape Town is one of South Africa's major healthcare and pharmaceutical centres, supported by modern hospitals, specialist clinics, and expanding healthcare infrastructure. As the demand for quality antimicrobial therapies continues to grow, healthcare providers increasingly rely on medicines manufactured according to internationally accepted pharmaceutical standards.
Indian pharmaceutical manufacturers continue to support healthcare systems worldwide through advanced production technology, internationally recognized quality management systems, and dependable pharmaceutical innovation.
Why Choose Indian Pharmaceutical Exports
India has established itself as one of the world's largest pharmaceutical manufacturing countries by consistently producing high-quality medicines.
Benefits of Indian Pharmaceutical Products
- WHO-GMP certified manufacturing facilities
- International pharmaceutical quality standards
- Advanced sterile manufacturing technology
- Reliable product consistency
- High pharmaceutical purity
- Modern quality assurance systems
- Export-grade packaging
- Continuous product quality monitoring
- Strong global healthcare reputation
- Innovative pharmaceutical manufacturing
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Strength | 562.5 mg |
| Composition | Ceftriaxone 500 mg + Tazobactam 62.5 mg |
| Dosage Form | Sterile Powder for Injection |
| Administration | IM / IV |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Dual-action antibiotic formulation
- Ceftriaxone and Tazobactam combination
- Broad-spectrum antibacterial activity
- Sterile injectable preparation
- WHO-GMP certified manufacturing
- High pharmaceutical purity
- Stable pharmaceutical formulation
- Batch-tested quality
- Export-quality packaging
- Manufactured according to international standards
Product Description
Ceftriaxone & Tazobactam Injection 562.5 mg combines the antibacterial action of Ceftriaxone with the beta-lactamase inhibiting properties of Tazobactam. This combination helps improve antibacterial effectiveness by protecting Ceftriaxone from bacterial enzymes that may reduce its activity.
The formulation is supplied as a sterile powder for injection and is administered through intramuscular (IM) or intravenous (IV) routes under medical supervision.
Mechanism of Action
The formulation provides antibacterial activity through two complementary mechanisms.
- Ceftriaxone prevents bacterial cell wall synthesis, leading to bacterial cell destruction.
- Tazobactam inhibits beta-lactamase enzymes that may inactivate certain antibiotics, allowing Ceftriaxone to maintain its antibacterial effectiveness.
Together they provide enhanced activity against susceptible bacterial pathogens.
Recommended Dosage
The appropriate dosage should always be determined by a qualified healthcare professional.
Treatment depends on:
- Type of bacterial infection
- Severity of illness
- Patient age
- Body weight
- Kidney function
- Overall clinical assessment
The medicine should only be administered under medical supervision.
Side Effects
Some individuals may experience temporary side effects.
Possible reactions include:
- Injection site pain
- Nausea
- Vomiting
- Diarrhea
- Headache
- Fever
- Skin rash
- Dizziness
- Allergic reactions
- Temporary changes in liver enzyme levels
Consult your healthcare provider if symptoms become severe or persistent.
Safety Information
- Prescription-only medicine.
- Use only under qualified medical supervision.
- Inform your doctor about any known allergies before treatment.
- Complete the prescribed treatment course.
- Follow all medical instructions carefully.
- Keep out of reach of children.
- Do not use after the expiry date.
Storage Information
- Store below 25°C
- Protect from moisture.
- Avoid direct sunlight.
- Store in the original packaging.
- Do not freeze.
- Use before the expiry date.
Quality Assurance
At Ernest Oncology, pharmaceutical quality is maintained throughout every stage of manufacturing.
Our Quality Standards
- WHO-GMP certified manufacturing facilities
- Sterile manufacturing environment
- Comprehensive batch quality testing
- Product traceability systems
- Export-quality packaging
- Controlled storage conditions
- Documentation verification
- Continuous quality improvement
Documentation
The following export documents are generally available:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP) (where applicable)
- Batch Manufacturing Record* (where available)
- Airway Bill / Bill of Lading
Partner with Ernest Oncology
Ernest Oncology is committed to improving healthcare through innovation, scientific excellence, and responsible pharmaceutical manufacturing. Every product is developed with a strong focus on quality, safety, and internationally accepted standards, helping healthcare professionals access dependable medicines manufactured in India.
Frequently Asked Questions (FAQs)
1. What does Ceftriaxone & Tazobactam Injection 562.5 mg contain?
It contains Ceftriaxone 500 mg and Tazobactam 62.5 mg in a sterile injectable formulation.
2. How is this injection administered?
It is administered through intramuscular (IM) or intravenous (IV) injection under the supervision of qualified healthcare professionals.
3. Why is Tazobactam combined with Ceftriaxone?
Tazobactam inhibits beta-lactamase enzymes, helping preserve the antibacterial effectiveness of Ceftriaxone.
4. How should this medicine be stored?
Store below 25°C, protected from moisture and direct sunlight, in its original packaging.
5. Is Ceftriaxone & Tazobactam Injection 562.5 mg a prescription medicine?
Yes. It should only be used under the guidance of a qualified healthcare professional.
📞 Contact Ernest Oncology — Healthcare Medicine Suppiler
A Specialized Healthcare Division of Ernest Pharmaceutical Pvt. Ltd.
🌐 Our Healthcare Platforms
- www.oncologymedicinesupplier.com
- www.ernestpharmaceuticals.com
- www.ernestvision.com
- www.ernestimpex.com
Email: exports@ernestpharmaceuticals.com
🌍 Our Commitment
- Innovative Pharmaceutical Solutions
- Trusted Oncology & Specialty Medicines
- Quality Manufacturing from India
- Advancing Healthcare Worldwide
+91 93599 02383
Medical Disclaimer
Ceftriaxone & Tazobactam Injection 562.5 mg is a prescription-only medicine. The information provided is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always use this medicine under the supervision of a qualified healthcare professional and according to approved prescribing guidelines.
- Ceftriaxone Sodium & Tazobactam Sodium Injection
- Ceftriaxone & Tazobactam Sterile Powder for Injection
- Ceftriaxone & Tazobactam IM/IV Injection
- Ceftriaxone & Tazobactam Dry Powder Injection
- Ceftriaxone & Tazobactam Broad-Spectrum Antibiotic Injection
Written By
Chaitali H.
B. Pharma
